Medicenna Therapeutics Corp. rose 10.0% on Friday, November 6, 2026, on 11,564 shares. No headline about MDNA came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Medicenna Therapeutics Corp. (MDNA:TSX) closed at $0.440 on November 6, 2026, up 10.00% on the day. The stock trades 75.3% below its 52-week high of $1.78 and 31.3% above its 52-week low of $0.335. Over the past year, it lost 69.7%. Medicenna Therapeutics Corp. is part of the Life Sciences sector (Biotechnology).
In 252 trading sessions since November 6, 2025, MDNA closed higher on 89 days (35%). Its best day was August 14, 2026 (+15.00%) and its worst was May 14, 2026 (-15.15%). The stock moved 10% or more in a single session 7 times. It opened at least 5% above the previous day's high 1 time.
Medicenna Therapeutics Corp is a clinical stage immuno-oncology company developing novel first-in-class, Interleukin-4 Empowered Cytokines (IL4-ECs) that specifically target the Interleukin-4 Receptor (IL4R).
Find more stocks like MDNA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.